Allotrope Medical company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Series A | Alive

Total Raised


Last Raised

$4M | 1 yr ago

About Allotrope Medical

Allotrope Medical has developed an electrical stimulation technology for smooth muscles that allows surgeons to identify critical tissue structures and distinguish functional from dysfunctional urologic and gastrointestinal issues. The company's mission is to provide a product that helps surgeons decrease ureter injury in minimally invasive surgical procedures.

Allotrope Medical Headquarter Location

2450 Holcombe Blvd. Suite X

Houston, Texas, 77021,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Allotrope Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Allotrope Medical is included in 3 Expert Collections, including Medical Devices.


Medical Devices

11,363 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).


Health IT

7,900 items

Allotrope Medical Patents

Allotrope Medical has filed 2 patents.

The 3 most popular patent topics include:

  • Implants (medicine)
  • Surgery
  • Digestive system surgery
patents chart

Application Date

Grant Date


Related Topics




Implants (medicine), Surgery, Surgical removal procedures, Surgical procedures and techniques, Digestive system surgery


Application Date


Grant Date



Related Topics

Implants (medicine), Surgery, Surgical removal procedures, Surgical procedures and techniques, Digestive system surgery



Latest Allotrope Medical News

Allotrope Medical Raises $4 Million in Series A Financing

Jun 2, 2021

Allotrope Medical Raises $4 Million in Series A Financing HOUSTON, June 1, 2021-- Allotrope Medical Inc., a medical device company whose FDA cleared product StimSite™ helps surgeons locate and identify ureters during pelvic surgery, announced the completion of an oversubscribed $4 million Series A financing. This round was led by Rockies Venture Club (RVC), with participation from notable investment groups including Aggie Angel Network, Bellingham Angels, Berkeley Angel Network, Kentucky Select Fund, MEDA Angels, Prosalus Capital, Seedfolio, Tech Coast Angels (Orange County and San Diego), and Texas Halo Fund among both existing and new investors. "RVC was honored to be able to support Allotrope Medical and lead their Series A raise. Allotrope Medical is at an exciting inflection point and is showing no signs of slowing down. Oversubscribing a funding round amid a pandemic is no easy feat," said Dave Harris, RVC Director of Operations. Many physician led groups also invested in this round. "Allotrope's StimSite system is addressing ureteral identification and protection, a well-known surgical risk for physicians and their patients" said Rob Olson, Bellingham Angel Investor and retired OB/GYN. "In addition to lowering surgical risk, StimSite integrates seamlessly with the physician's existing workflow and tools, thereby streamlining adoption. In our assessment, these factors make StimSite an attractive product and Allotrope a promising investment". Allotrope Medical Closes Oversubscribed Series A Investment Round "We are both humbled and excited to have the support of so many individuals and groups," said Albert Huang, MD, Founder and Chief Executive Office of Allotrope Medical. "With the financing of this round, we will continue to accelerate our commercialization plans and see our elegant and easy to use technology improve the surgical experience for physicians and patients across the US." About Allotrope Medical Allotrope Medical is a commercial stage medical device company that has developed StimSite™ – a FDA cleared smooth muscle stimulation device that leverages the surgeon's existing laparoscopic and robotic instruments to rapidly and safely help identify and locate the ureter during pelvic operations. StimSite™ connects with on-market surgical instruments with no modification to ensure seamless workflow integration and ease of universal connectivity and installation in any operating room in minutes. Contact:

Allotrope Medical Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Allotrope Medical Rank

  • When was Allotrope Medical founded?

    Allotrope Medical was founded in 2016.

  • Where is Allotrope Medical's headquarters?

    Allotrope Medical's headquarters is located at 2450 Holcombe Blvd., Houston.

  • What is Allotrope Medical's latest funding round?

    Allotrope Medical's latest funding round is Series A.

  • How much did Allotrope Medical raise?

    Allotrope Medical raised a total of $4.12M.

  • Who are the investors of Allotrope Medical?

    Investors of Allotrope Medical include Rockies Venture Club, seedfolio, Prosalus Capital, NuFund Venture Group, Aggie Angel Network and 11 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.